Joseph M. Feczko - 21 Jan 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Jan 2022
Net transactions value
+$577,750
Form type
4
Filing time
25 Jan 2022, 19:03:40 UTC
Previous filing
24 May 2021
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Options Exercise $397,500 +25,000 +23% $15.90 135,627 21 Jan 2022 Direct
transaction CCXI Common Stock Options Exercise $180,250 +12,500 +9.2% $14.42 148,127 21 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Stock Option (right to buy) Options Exercise -25,000 -100% 0 21 Jan 2022 Common Stock 25,000 $15.90 Direct F1, F2
transaction CCXI Stock Option (right to buy) Options Exercise -12,500 -100% 0 21 Jan 2022 Common Stock 12,500 $14.42 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of January 21, 2022, and prior to this transaction, the exercised options were fully vested.
F2 Not applicable.